Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2026-01-19 @ 8:08 AM
Study NCT ID:
NCT06590857
Status:
RECRUITING
Last Update Posted:
2025-08-12
First Post:
2024-09-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
Sponsor:
RayzeBio, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-19
Start Date Type:
ACTUAL
Primary Completion Date:
2028-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-09-03
First Submit QC Date:
None
Study First Post Date:
2024-09-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-07
Last Update Post Date:
2025-08-12
Last Update Post Date Type:
ACTUAL